EUVIMEDTutustu EUVIMEDiin
Crossref

Tectorigenin protects against muscle atrophy from in vitro nutrient deprivation and in vivo denervation by activating the AMPK/SIRT1/PGC‐1α pathway

Boya Liu, Fei Xue, Xingxing Fang, Xiaoming Yang, Junyang Chen, Zihui Gao, Hua Liu, Jiacheng Sun, Yuntian Shen, Xinlei Yao, Bingqian Chen, Hualin Sun iD

British Journal of Pharmacology · 2026-12 · 183 (23) · 6945-6965

DOI: 10.1111/bph.70653 ↗

At a glance

Journal article in British Journal of Pharmacology, published online on 2026-08-24. Written by Boya Liu and 11 co-authors. Institution: Jiangsu Key Laboratory of Tissue Engineering and Neuroregeneration, Key Laboratory of Neuroregeneration of Ministry of Education, Co-innovation Cente…. Major MEDLINE topics: Sirtuin 1, Muscular Atrophy, Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, Isoflavones. Cited 4 times so far (Crossref); 71 references. Funded by: Natural Science Foundation of Jiangsu Province, National Natural Science Foundation of China, Nantong Science and Technology Bureau.

TiivistelmäSubjectsBibliografiset tiedotCiteRelated studies

Abstract (original language)

Background and Purpose The molecular mechanisms underlying denervation‐induced muscle atrophy remain incompletely understood, and effective therapeutic interventions are currently lacking. Tectorigenin (TG), a natural isoflavonoid, has demonstrated antioxidant and metabolic regulatory activities. This study investigated whether TG also alleviates denervation‐induced muscle atrophy via activation of the AMPK/SIRT1/PGC‐1α signalling pathway. Experimental Approach A sciatic nerve transection model was established in ICR mice to evaluate the therapeutic effects of TG. Histomorphology, oxidative stress markers, mitochondrial function and pathway activity were assessed. A nutrient deprivation‐induced C2C12 myotube atrophy model was used for in vitro validation. Pathway‐specific inhibitors (Compound C, EX‐527 and SR18292) were applied both in vivo and in vitro to confirm mechanistic involvement. Key Results TG treatment significantly improved muscle wet weight ratio, myofibre cross‐sectional area and myosin heavy chain expression in denervated mice. It reduced levels of atrophy‐related ubiquitin ligases, attenuated oxidative stress and improved mitochondrial integrity. TG reversed the denervation‐induced suppression of AMPK/SIRT1/PGC‐1α signalling and downstream effectors. In C2C12 myotubes, TG dose‐dependently ameliorated atrophy and up‐regulated SIRT1/PGC‐1α. Pharmacological inhibition of AMPK, SIRT1 or PGC‐1α abolished TG's protective effects, both in vitro and in vivo. Conclusions and Implications TG mitigates denervation‐induced muscle atrophy through a multi‐mechanistic approach involving activation of the AMPK/SIRT1/PGC‐1α axis, enhancement of mitochondrial dynamics and restoration of redox homeostasis. This study identifies TG as a promising candidate for clinical translation in the treatment of neurogenic muscle atrophy.

Subjects

MeSH terms (MEDLINE)

Sirtuin 1Muscular AtrophyPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaIsoflavonesAMP-Activated Protein KinasesAnimalsMaleSignal TransductionMiceMice, Inbred ICROxidative StressCell LineSciatic NerveMuscle, Skeletal

Author keywords

AMPK/SIRT1/PGC‐1α signalling pathwaydenervation‐induced muscle atrophymitochondriatectorigenin

Substances

Sirtuin 1Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaIsoflavonesAMP-Activated Protein KinasesSirt1 protein, mousePpargc1a protein, mouse

Authors and institutions

  • Jiangsu Key Laboratory of Tissue Engineering and Neuroregeneration, Key Laboratory of Neuroregeneration of Ministry of Education, Co-innovation Center of Neuroregeneration, Nantong University, Nantong, Jiangsu, China.
  • Department of Nephrology, Affiliated Hospital 2 of Nantong University and First People's Hospital of Nantong City, Nantong, Jiangsu, China.
  • Department of Orthopedics, Changshu Hospital Affiliated to Soochow University, First People's Hospital of Changshu City, Changshu, Jiangsu, China.

ORCID profiles: Hualin Sun

Funding

  • Natural Science Foundation of Jiangsu Province
  • National Natural Science Foundation of China
  • Nantong Science and Technology Bureau
  • Natural Science Research Projects in Universities of Jiangsu Province
  • Research Project of the Jiangsu Provincial Health Commission
  • Suzhou Science and Technology Development Program
  • Nantong Municipal Science and Technology Bureau

Cite

APA

Liu, B., Xue, F., Fang, X., Yang, X., Chen, J., Gao, Z., Liu, H., Sun, J., Shen, Y., Yao, X., Chen, B., & Sun, H. (2026). Tectorigenin protects against muscle atrophy from in vitro nutrient deprivation and in vivo denervation by activating the AMPK/SIRT1/PGC‐1α pathway. British Journal of Pharmacology, 183(23), 6945-6965. https://doi.org/10.1111/bph.70653

Vancouver

Liu B, Xue F, Fang X, Yang X, Chen J, Gao Z, et al. Tectorigenin protects against muscle atrophy from in vitro nutrient deprivation and in vivo denervation by activating the AMPK/SIRT1/PGC‐1α pathway. British Journal of Pharmacology. 2026;183(23):6945-6965. doi:10.1111/bph.70653

BibTeX
@article{Liu2026,
  author = {Liu, Boya and Xue, Fei and Fang, Xingxing and Yang, Xiaoming and Chen, Junyang and Gao, Zihui and Liu, Hua and Sun, Jiacheng and Shen, Yuntian and Yao, Xinlei and Chen, Bingqian and Sun, Hualin},
  title = {Tectorigenin protects against muscle atrophy from in vitro nutrient deprivation and in vivo denervation by activating the AMPK/SIRT1/PGC‐1α pathway},
  journal = {British Journal of Pharmacology},
  year = {2026},
  volume = {183},
  number = {23},
  pages = {6945--6965},
  doi = {10.1111/bph.70653}
}
Start for free →